These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25420465)

  • 21. Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation.
    Chapman KL; Holzgrefe H; Black LE; Brown M; Chellman G; Copeman C; Couch J; Creton S; Gehen S; Hoberman A; Kinter LB; Madden S; Mattis C; Stemple HA; Wilson S
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):88-103. PubMed ID: 23524271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature.
    Boczkowski J; Hoet P
    Nanotoxicology; 2010 Mar; 4(1):1-14. PubMed ID: 20795899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NANOSAFETY. How safe are nanomaterials?
    Valsami-Jones E; Lynch I
    Science; 2015 Oct; 350(6259):388-9. PubMed ID: 26494749
    [No Abstract]   [Full Text] [Related]  

  • 24. Join the dialogue.
    Nat Nanotechnol; 2012 Sep; 7(9):545. PubMed ID: 22902961
    [No Abstract]   [Full Text] [Related]  

  • 25. 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.
    Weil CS
    Am Ind Hyg Assoc J; 1984 Oct; 45(10):663-70. PubMed ID: 6496314
    [No Abstract]   [Full Text] [Related]  

  • 26. Rethinking Nanosafety Part II: Leveraging Progress to Pioneer New Approaches and Solutions.
    Chen C; Leong D; Lynch I
    Small; 2020 Sep; 16(36):e2004934. PubMed ID: 32909354
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety pharmacology investigations in toxicology studies: an industry survey.
    Authier S; Vargas HM; Curtis MJ; Holbrook M; Pugsley MK
    J Pharmacol Toxicol Methods; 2013; 68(1):44-51. PubMed ID: 23685201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression, dose-response, and phenotypic anchoring: applications for toxicogenomics in risk assessment.
    Daston GP
    Toxicol Sci; 2008 Oct; 105(2):233-4. PubMed ID: 18684776
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacologic considerations in the design of toxicology experiments.
    Darby TD
    Clin Toxicol; 1978 Feb; 12(2):229-38. PubMed ID: 648118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicology and risk assessment conference 2009. Toxicology and risk assessment from the trenches: an overview.
    Rieth SH; Chapman GD
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):138-40. PubMed ID: 21740991
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methodological research problems in age-related toxicology].
    Savchenkov MF
    Gig Sanit; 1979 Nov; (11):58-61. PubMed ID: 499861
    [No Abstract]   [Full Text] [Related]  

  • 32. Research design from the academic toxicological viewpoint.
    Witschi H
    Clin Toxicol; 1979 Dec; 15(5):571-82. PubMed ID: 546582
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent developments in nanotoxicology.
    Bolt HM; Marchan R; Hengstler JG
    Arch Toxicol; 2013 Jun; 87(6):927-8. PubMed ID: 22526375
    [No Abstract]   [Full Text] [Related]  

  • 35. American College of Toxicology: policy statement on the use of animals in toxicology.
    American College of Toxicology
    Int J Toxicol; 2005; 24(1):1 p preceding 1. PubMed ID: 15984058
    [No Abstract]   [Full Text] [Related]  

  • 36. American College of Toxicology: policy statement on the use of animals in toxicology.
    Int J Toxicol; 2002; 21(2):2p preceding 81. PubMed ID: 12022633
    [No Abstract]   [Full Text] [Related]  

  • 37. Biopharmaceutical studies, a key to better toxicology.
    Zbinden G
    Xenobiotica; 1988 Jan; 18 Suppl 1():9-14. PubMed ID: 3344592
    [No Abstract]   [Full Text] [Related]  

  • 38. Developmental toxicology: adequacy of current methods.
    Peters PW
    Food Addit Contam; 1998; 15 Suppl():55-62. PubMed ID: 9602913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotoxicology and oxidative stress control: cutting-edge topics in toxicology.
    Bolt HM; Marchan R; Hengstler JG
    Arch Toxicol; 2012 Nov; 86(11):1629-35. PubMed ID: 23052200
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.